Since then, researchers have demonstrated that B2M can promote the growth of human renal cell carcinoma [21] by activating the protein kinase A, cyclic adenosine monophosphate response element binding protein, and vascular endothelial growth factor axis. Here, VEGFA is linked to hereditary clear cell renal cell carcinoma.